(Q30659904)

26 June 2017

title

Active drug targeting with immunoconjugates to choroidal neovascularization (English)

1 reference

26 June 2017

1 reference

T Yasukawa

1

1 reference

26 June 2017

H Kimura

2

1 reference

26 June 2017

Y Tabata

3

1 reference

26 June 2017

H Miyamoto

4

1 reference

26 June 2017

Y Honda

5

1 reference

26 June 2017

Y Ikada

6

1 reference

26 June 2017

Y Ogura

7

1 reference

26 June 2017

publication date

1 December 2000

1 reference

26 June 2017

1 reference

26 June 2017

volume

21

1 reference

26 June 2017

issue

6

1 reference

26 June 2017

page(s)

952-961

1 reference

Radiation therapy for ocular choroidal neovascularization (phase I/II study): preliminary report

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

Radiation therapy for subretinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470).

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

TNP-470 (AGM-1470): mechanisms of action and early clinical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

Preparation and properties of the immunoconjugate composed of anti-human colon cancer monoclonal antibody and mitomycin C-dextran conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

Subretinal neovascularization. Natural history of an experimental model

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

Recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy treated with daily doses of thalidomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

PEG-ADA: an alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

Chorioretinal damage caused by the excision of choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

Photodynamic therapy of subretinal neovascularization in the monkey eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

Experimental subretinal neovascularization in the monkey. Permeability of new vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

Disposition and tumor localization of mitomycin C-dextran conjugates in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.21.6.952.6992

10.1076/CEYR.21.6.952.6992

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference